Requires health insurance coverage of diagnostic and supplemental breast examinations without cost-sharing.
Impact
The bill is positioned to significantly enhance access to critical healthcare for many individuals, particularly women at higher risk for breast cancer. By eliminating cost-sharing for these examinations, A3128 seeks to reduce financial barriers that may discourage patients from seeking timely care. This could lead to earlier detection and treatment of breast cancer, ultimately improving health outcomes among those eligible for coverage under various insurance plans, including those who participate in high-deductible health plans.
Summary
Bill A3128, introduced in the New Jersey legislature, mandates that all health insurance providers offer coverage for both diagnostic and supplemental breast examinations without imposing any cost-sharing requirements on policyholders. The legislation aims to ensure that patients can access necessary medical evaluations for breast cancer without facing deductibles, copayments, or other out-of-pocket costs. This requirement is to be applied uniformly across all medical service corporations and health benefit plans, including group and individual policies issued within the state.
Contention
While the intent of Bill A3128 is generally seen as positive, providing necessary healthcare access, there may be concerns regarding the financial implications for insurance providers. Critics could argue that the mandate may lead to increased insurance premiums or narrower provider networks as insurers adjust to the requirements that might mandate additional payouts for covered procedures. Nevertheless, supporters emphasize the importance of prioritizing patient health and preventive care over potential cost concerns for insurers.